Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy KemPharm stock

Learn how to easily invest in KemPharm stock.

KemPharm is currently traded as an over-the-counter (OTC) stock, which means that some shares are available, but not easy to access. The company plans to list on the Nasdaq, which will make it easy to buy shares from any major brokerage account. Here's how.

How to buy KemPharm stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – KMPH. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for social trading

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for active trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

KemPharm stock price (NASDAQ: KMPH)

Use our graph to track the performance of KMPH stocks over time.

KemPharm shares at a glance

Information last updated 2023-07-02.
Latest market close$4.97
52-week range$4.05 - $6.65
50-day moving average $5.32
200-day moving average $5.27
Wall St. target price$22.33
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.91

Buy KemPharm stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 7 of 7
Name Product Ratings Available asset types Minimum deposit Signup bonus
SoFi Invest
Finder Rating: 4.6 / 5: ★★★★★

Finder Award
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Rating: 4.2 / 5: ★★★★★

Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Finder Rating: 4.1 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
2.5% fee applies to all alternative asset transactions.
Finder Rating: 4.2 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4.9% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Finder Rating: 4 / 5: ★★★★★
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs
Wealthfront builds a free financial plan for the life you want and automate your investments at a low cost.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy KemPharm stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

KemPharm price performance over time

Historical closes compared with the close of $4.97 from 2023-05-03

1 week (2023-09-11) N/A
1 month (2023-08-18) N/A
3 months (2023-06-18) N/A
6 months (2023-03-22) -7.96%
1 year (2022-09-22) -16.47%
2 years (2021-09-18) N/A
3 years (2020-09-22) 11.144
5 years (2018-09-21) 72

KemPharm financials

Revenue TTM $10.7 million
Gross profit TTM $26.6 million
Return on assets TTM -8.97%
Return on equity TTM -31.24%
Profit margin 0%
Book value $2.72
Market Capitalization $200.5 million

TTM: trailing 12 months

KemPharm share dividends

We're not expecting KemPharm to pay a dividend over the next 12 months.

You may also wish to consider:

Have KemPharm's shares ever split?

KemPharm's shares were split on a 1:16 basis on 28 December 2020. So if you had owned 16 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your KemPharm shares – just the quantity. However, indirectly, the new 1500% higher share price could have impacted the market appetite for KemPharm shares which in turn could have impacted KemPharm's share price.

KemPharm share price volatility

Over the last 12 months, KemPharm's shares have ranged in value from as little as $4.05 up to $6.65. A popular way to gauge a stock's volatility is its "beta".

KMPH.US volatility(beta: 2.16)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while KemPharm's is 2.1586. This would suggest that KemPharm's shares are significantly more volatile than the average for this exchange and represent a higher risk.

To put KemPharm's beta into context you can compare it against those of similar companies.

KemPharm overview

Zevra Therapeutics, Inc. , a rare disease therapeutics company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. Its prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, stimulant use disorder, and CNS rare diseases, including idiopathic hypersomnia (IH). The company's lead product candidate KP1077, which is under Phase II clinical trial for the treatment of IH and narcolepsy, is based on its prodrug of d-methylphenidate, known as serdexmethylphnidate. It is also developing KP879, a prodrug product candidate for the treatment of stimulant use disorder and is under Phase I clinical trial. In addition, the company has received FDA approval for AZSTARYS, a new once-daily treatment for attention deficit hyperactivity disorder in patents age six years and older, and for APADAZ, an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone, and acetaminophen.

Frequently asked questions

What percentage of KemPharm is owned by insiders or institutions?
Currently 10.29% of KemPharm shares are held by insiders and 17.687% by institutions.
How many people work for KemPharm?
Latest data suggests 24 work at KemPharm.
When does the fiscal year end for KemPharm?
KemPharm's fiscal year ends in December.
Where is KemPharm based?
KemPharm's address is: 1180 Celebration Boulevard, Celebration, FL, United States, 34747
What is KemPharm's ISIN number?
KemPharm's international securities identification number is: US4884452065
What is KemPharm's CUSIP number?
KemPharm's Committee on Uniform Securities Identification Procedures number is: 488445107

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site